Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Absolute bioavailability study of cenerimod in healthy male participants
NL-OMON58702Phase 1Completed
- Sponsor
- Viatris
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, single-arm trial of cenerimod, sponsored by Viatris. Primary endpoint: Primary endpoint(s). Started Nov 2025; status: completed.
02
Drugs
cenerimod
Beyond the preview
Go deeper on NL-OMON58702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON58702.